EDITORIAL
Published on 24 Sep 2024
Editorial: Treating solid organ diseases with innovative chimeric-antigen receptor T-cells: current indications, progress, limitations and potential strategies
doi 10.3389/fimmu.2024.1491982
- 362 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Treating Solid Organ Diseases with Innovative Chimeric-Antigen Receptor T-cells: Current indications, progress, limitations and potential strategies
Treating Solid Organ Diseases with Innovative Chimeric-Antigen Receptor T-cells: Current indications, progress, limitations and potential strategies
7,060
Total downloads
21k
Total views and downloads
Articles
SYSTEMATIC REVIEW
Published on 10 May 2024
The synergistic immunotherapeutic impact of engineered CAR-T cells with PD-1 blockade in lymphomas and solid tumors: a systematic review
doi 10.3389/fimmu.2024.1389971
- 2,024 views
- 3 citations
ORIGINAL RESEARCH
Published on 18 Mar 2024
Universal CAR T cells targeted to HER2 with a biotin-trastuzumab soluble linker penetrate spheroids and large tumor xenografts that are inherently resistant to trastuzumab mediated ADCC
doi 10.3389/fimmu.2024.1365172
- 2,956 views
- 4 citations
ORIGINAL RESEARCH
Published on 14 Mar 2024
Low-dose targeted radionuclide therapy synergizes with CAR T cells and enhances tumor response
doi 10.3389/fimmu.2024.1355388
- 1,997 views
- 3 citations
MINI REVIEW
Published on 22 Feb 2024
Recent advances on CAR-T signaling pave the way for prolonged persistence and new modalities in clinic
doi 10.3389/fimmu.2024.1335424
- 4,903 views
- 8 citations
REVIEW
Published on 31 Oct 2022
Chimeric antigen receptor T cells applied to solid tumors
doi 10.3389/fimmu.2022.984864
- 5,104 views
- 16 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore